Stock ANTRIABIO INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar AntriaBio Inc OTC Bulletin Board

Equities

US0372301095

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for AntriaBio Inc
05-22 Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell MT
05-22 Top Premarket Gainers MT

Chart calendar AntriaBio Inc

503018ac1e1f8407f192d860913ba.vL3BONut_sQuMZBCnDInDWXgRtqtCGQrONx11xOEJg0.1-K1drHkjIF9AeYL2wJ9PQq6KIrgUSgcaJgBllDTfnXaiKsKrsa18Ed__w~4aabe53377c14a6259393da14b28f935

Upcoming events on AntriaBio Inc

2024-06-06 13:00 Jefferies Global Healthcare Conference
2024-09-11 Q4 2024 Earnings Release (Projected)
2024-11-06 Q1 2025 Earnings Release (Projected)
2025-02-04 Q2 2025 Earnings Release (Projected)
2025-05-19 Q3 2025 Earnings Release (Projected)

Past events on AntriaBio Inc

2024-05-21 17:30 RZ402-201 Phase 2 Study Results Call
2024-05-16 18:00 Annual General Meeting
2024-05-15 16:05 Q3 2024 Earnings Release
2024-05-14 12:30 JMP Securities Life Sciences Conference
2024-05-04 13:15 Pediatric Endocrine Society Meeting - Abstract No : 6790
2024-02-13 16:05 Q2 2024 Earnings Release
2023-11-27 14:30 BTIG Ophthalmology Day
2023-11-13 16:05 Q1 2024 Earnings Release
2023-09-26 14:10 Cantor Global Healthcare Conference
2023-09-14 16:05 Q4 2023 Earnings Release
2023-09-12 14:00 H.C. Wainwright Global Investment Conference
2023-06-27 16:30 RZ358 Phase3 Update Call
2023-05-25 18:00 Annual General Meeting
2023-05-11 16:05 Q3 2023 Earnings Release
2023-03-22 16:30 Investor Meeting - Key Opinion Leader
2023-02-10 16:05 Q2 2023 Earnings Release
2022-11-17 11:25 Jefferies London Healthcare Conference
2022-11-09 16:05 Q1 2023 Earnings Release
2022-11-03 13:47 Retina Society Scientific Meeting
2022-09-15 16:05 FY 2022 Earnings Release

Annual results

Fiscal PeriodGiugno 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-25,9
-31,3
17.11%		0,00
0,00
- 		-22,9
-22,5
-1.68%		-41,8
-45,1
7.27%		-56,0
-60,0
6.65%
-66,2

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-30,4
-35,8
14.96%		0,00
0,00
- 		-20,9
-22,1
5.26%		-41,1
-46,7
12.08%		-51,8
-58,0
10.74%
-63,6

Net income
Million USD		Released
Forecast
Spread 		-30,4
-35,8
14.96%		-20,3
-21,8
6.73%		-20,9
-21,6
3.15%		-41,1
-46,7
12.08%		-51,8
-57,8
10.46%
-63,8

EPS
USD		Released
Forecast
Spread 		-18,5
-15,0
-23.33%		-3,54
-4,00
11.5%		-2,72
-2,82
3.63%		-2,26
-2,48
8.99%		-1,01
-1,22
17.35%
-1,17

Announcement Date10/09/1913/10/2015/09/2115/09/2214/09/23-

Quarterly results

Fiscal PeriodGiugno 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


28,8

EBIT
Million USD		Released
Forecast
Spread 		-10,8
-15,5
30.66%		-11,3
-14,6
22.58%		-10,2
-12,2
16.06%		-14,4
-15,5
7.41%		-17,1
-15,7
-8.84%		-14,2
-18,2
21.82%		-15,9
-16,5
3.52%		-15,2
-18,1
15.94%		-16,2
-16,8
3.69%
-18,3


-18,0


-19,2


-20,4


36,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-11,2
-16,2
30.67%		-9,42
-15,1
37.5%		-9,83
-12,4
20.86%		-13,6
-13,5
-0.27%		-15,7
-15,6
-0.51%		-12,7
-18,5
31.21%		-14,5
-16,4
11.25%		-13,9
-16,7
16.57%		-17,1
-16,2
-4.93%
-18,7


-18,0


-19,2


-20,4


36,4

Net income
Million USD		Released
Forecast
Spread 		-11,2
-15,9
29.62%		-9,42
-15,1
37.5%		-9,83
-12,4
20.86%		-13,6
-13,5
-0.27%		-15,7
-15,6
-0.51%		-12,7
-18,5
31.21%		-14,5
-13,5
-7.86%		-13,9
-16,9
17.58%		-17,1
-16,2
-4.93%
-18,7


-18,0


-19,2


-20,4


36,4

EPS
USD		Released
Forecast
Spread 		-0,65
-0,91
28.26%		-0,30
-0,56
45.95%		-0,19
-0,31
39.36%		-0,26
-0,32
18.24%		-0,30
-0,30
0%		-0,25
-0,36
29.78%		-0,28
-0,28
0.88%		-0,27
-0,29
6.9%		-0,34
-0,30
-11.74%
-0,31


-0,29


-0,28


-0,27


0,13

Announcement Date12/05/2215/09/2209/11/2210/02/2311/05/2314/09/2313/11/2313/02/2415/05/24-----

Upcoming sector events for AntriaBio Inc

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for AntriaBio Inc

2024-05-17 07:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
2024-05-15 08:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-14 16:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 16:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. RZLT Stock
  4. Stock
  5. Calendar AntriaBio Inc